In the first application, we focus on colorectal cancer (CRC) in carriers of the pathogenic variant PMS2, and in the second application, we analyze the association between a polygenic risk score (PRS) based on common breast cancer‐associated variants and breast cancer risk in multiple case families. Here, PMS2 is linked to breast cancer.